Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS 2b”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02448641
What this trial is testing

Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke

Who this might be right for
Chronic Ischemic Stroke
SanBio, Inc. 163
Testing effectiveness (Phase 2)Study completedNCT00245622
What this trial is testing

Autologous T Cell Vaccine (TCV) for Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Opexa Therapeutics, Inc. 150
Large-scale testing (Phase 3)Active Not RecruitingNCT06125951
What this trial is testing

Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease

Who this might be right for
Dementia ModerateDementia, MildAlzheimer Disease
Actinogen Medical 247
Testing effectiveness (Phase 2)Study completedNCT06402123
What this trial is testing

A Phase 2b Study of Zagociguat in Patients With MELAS

Who this might be right for
Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)
Tisento Therapeutics 43
Large-scale testing (Phase 3)Study completedNCT01968460
What this trial is testing

Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
Pharma Two B Ltd. 149
Testing effectiveness (Phase 2)Study completedNCT01721733
What this trial is testing

Safety and Efficacy Study of EPI-743 in Children With Leigh Syndrome

Who this might be right for
Leigh Syndrome
PTC Therapeutics 35
Testing effectiveness (Phase 2)Study completedNCT02669433
What this trial is testing

Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study

Who this might be right for
Dementia With Lewy Bodies
Axovant Sciences Ltd. 484
Large-scale testing (Phase 3)Study completedNCT06122662
What this trial is testing

AMX0035 and Progressive Supranuclear Palsy

Who this might be right for
Progressive Supranuclear PalsyPSPNeurodegenerative Diseases+1 more
Amylyx Pharmaceuticals Inc. 139
Testing effectiveness (Phase 2)WithdrawnNCT00561366
What this trial is testing

A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
CytRx
Testing effectiveness (Phase 2)Study completedNCT02228213
What this trial is testing

Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
Innate Immunotherapeutics 93
Large-scale testing (Phase 3)Ended earlyNCT04857359
What this trial is testing

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-InducedDyskinesias
Addex Pharma S.A. 25
Early research (Phase 1)Study completedNCT02707965
What this trial is testing

Characterization of Epilepsy Patients BEEP 2b

Who this might be right for
Epilepsy
Food and Drug Administration (FDA) 21
Not applicableLooking for participantsNCT03737786
What this trial is testing

SEACOAST 1- SEdAtion With COllAteral Support in Endovascular Therapy for Acute Ischemic Stroke

Who this might be right for
Acute Stroke
University of California, Los Angeles 90
Testing effectiveness (Phase 2)Ended earlyNCT02222948
What this trial is testing

Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Genzyme, a Sanofi Company 112
Testing effectiveness (Phase 2)Study completedNCT05348785
What this trial is testing

Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80

Who this might be right for
Parkinson Disease
Biogen 650
Testing effectiveness (Phase 2)Ended earlyNCT06220669
What this trial is testing

LY3541860 in Adult Participants With Relapsing Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Eli Lilly and Company 63
Large-scale testing (Phase 3)Ended earlyNCT03879655
What this trial is testing

Open-label Study of VTS-270 in Participants With Neurologic Manifestations of Niemann-Pick Type C1

Who this might be right for
Niemann-Pick Disease, Type C
Mandos LLC 2
Testing effectiveness (Phase 2)Ended earlyNCT01464788
What this trial is testing

Randomized Controlled Trial of Argatroban With Tissue Plasminogen Activator (tPA) for Acute Stroke

Who this might be right for
Ischemic Stroke
Andrew D. Barreto, MD 90
Testing effectiveness (Phase 2)Study completedNCT04479449
What this trial is testing

Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPA

Who this might be right for
Ischemic Stroke
Shin Poong Pharmaceutical Co. Ltd. 178
Testing effectiveness (Phase 2)Study completedNCT01777555
What this trial is testing

Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes

Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 89
Next Page